Literature DB >> 25840681

Functional Exposed Amino Acids of BauA as Potential Immunogen Against Acinetobacter baumannii.

Fatemeh Sefid1, Iraj Rasooli, Abolfazl Jahangiri, Hadise Bazmara.   

Abstract

Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult antimicrobial-resistant gram negative bacilli to control and treat. One of the major challenges that the pathogenic bacteria face in their host is the scarcity of freely available iron. To survive under such conditions, bacteria express new proteins on their outer membrane and also secrete iron chelators called siderophores. Antibodies directed against these proteins associated with iron uptake exert a bacteriostatic or bactericidal effect against A. baumanii in vitro, by blocking siderophore mediated iron uptake pathways. Attempts should be made to discover peptides that could mimic protein epitopes and possess the same immunogenicity as the whole protein. Subsequently, theoretical methods for epitope prediction have been developed leading to synthesis of such peptides that are important for development of immunodiagnostic tests and vaccines. The present study was designed to in silico resolving the major obstacles in the control or in prevention of the diseases caused by A. baumannii. We exploited bioinformatic tools to better understand and characterize the Baumannii acinetobactin utilization structure of A. baumannii and select appropriate regions as effective B cell epitopes. In conclusion, amino acids 26-191 of cork domain and 321-635 of part of the barrel domain including L4-L9, were selected as vaccine candidates. These two regions contain functional exposed amino acids with higher score of B cell epitopes properties. Majority of amino acids are hydrophilic, flexible, accessible, and favorable for B cells from secondary structure point of view.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840681     DOI: 10.1007/s10441-015-9251-2

Source DB:  PubMed          Journal:  Acta Biotheor        ISSN: 0001-5342            Impact factor:   1.774


  7 in total

1.  Designing a less immunogenic nattokinase from Bacillus subtilis subsp. natto: a computational mutagenesis.

Authors:  Yoanes Maria Vianney; Stanley Evander Emeltan Tjoa; Reza Aditama; Sulisyto Emantoko Dwi Putra
Journal:  J Mol Model       Date:  2019-11-09       Impact factor: 1.810

2.  In-Silico Vaccine Design Based on a Novel Vaccine Candidate Against Infections Caused by Acinetobacter baumannii.

Authors:  Kashaf Khalid; Sidra Irum; Sidra Rahmat Ullah; Saadia Andleeb
Journal:  Int J Pept Res Ther       Date:  2021-12-02       Impact factor: 1.931

Review 3.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

4.  Hybrid antigens expressing surface loops of BauA from Acinetobacter baumannii are capable of inducing protection against infection.

Authors:  Somshukla Chaudhuri; Iraj Rasooli; Ramin Hatefi Oskouei; Mahdi Pishgahi; Abolfazl Jahangir; Vahid Farshchi Andisi; Anthony B Schryvers
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

5.  Conserved OprF as a Selective Immunogen against Pseudomonas aeruginosa.

Authors:  Ehsan Kazemi Moghaddam; Parviz Owlia; Abolfazl Jahangiri; Iraj Rasooli; Mohammad Reza Rahbar; Marjan Aghajani
Journal:  Iran J Pathol       Date:  2017-04-01

6.  Immunogenicity of Cork and Loop Domains of Recombinant Baumannii acinetobactin Utilization Protein in Murine Model.

Authors:  Hamid Esmaeilkhani; Iraj Rasooli; Masoomeh Hashemi; Shahram Nazarian; Fatemeh Sefid
Journal:  Avicenna J Med Biotechnol       Date:  2019 Apr-Jun

7.  Hybrid Antigens Expressing Surface Loops of ZnuD From Acinetobacter baumannii Is Capable of Inducing Protection Against Infection.

Authors:  Maryam Mobarak Qamsari; Iraj Rasooli; Somshukla Chaudhuri; Shakiba Darvish Alipour Astaneh; Anthony B Schryvers
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.